Iterative and prolonged remission in metastatic breast cancer using pegylated irinotecan: a case report.

about

Iterative and prolonged remission in metastatic breast cancer using pegylated irinotecan: a case report.

Item

http://www.wikidata.org/entity/Q35599716

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@ast

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@en

type

Item

label

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@ast

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@en

prefLabel

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@ast

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@en

P1476

Iterative and prolonged remiss ...... ted irinotecan: a case report.

@en

P2093

Hassan Errihani

http://www.w3.org/2001/XMLSchema#string

Maha Mokrim

http://www.w3.org/2001/XMLSchema#string

Martine J Piccart

http://www.w3.org/2001/XMLSchema#string

Mounia Amzerin

http://www.w3.org/2001/XMLSchema#string

P2860

Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond.

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors

Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.

Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available.

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.

Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens.

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

When to order a biopsy to characterise a metastatic relapse in breast cancer.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/1752-1947-9-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276297547

http://www.w3.org/2001/XMLSchema#string

P698

25971303

http://www.w3.org/2001/XMLSchema#string

P932

4429498

http://www.w3.org/2001/XMLSchema#string